|
Market Closed -
Nasdaq
16:00:00 2026-10-07 EDT
|
5-day change | 1st Jan Change | ||
| 16.42 USD | -6.17% |
|
-9.58% | - |
| 09-20 | Attovia Therapeutics, Inc.(NasdaqGM:ATTO) added to S&P TMI Index | CI |
| 09-16 | Attovia Therapeutics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 10:00 AM |
Company Valuation: Attovia Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2026 | 2027 | 2028 |
|---|---|---|---|
| Market Cap 1 | 749.6 | - | - |
| Change | - | - | - |
| Enterprise Value (EV) 1 | 370.6 | 463.5 | 241.6 |
| Change | - | 25.05% | -47.86% |
| P/E | -5.91x | -7.84x | -6.74x |
| PBR | 2x | 2.76x | 1.78x |
| PEG | -0.1x | 0.3x | -0.4x |
| Capitalization / Revenue | 1,606x | - | - |
| EV / Revenue | 794x | - | - |
| EV / EBITDA | -4.12x | -3.87x | -1.72x |
| EV / EBIT | -4.09x | -3.86x | -1.71x |
| EV / FCF | -3.95x | -4.07x | -1.83x |
| FCF Yield | -25.3% | -24.6% | -54.7% |
| Dividend per Share 2 | - | - | - |
| Rate of return | - | - | - |
| EPS 2 | -2.779 | -2.096 | -2.437 |
| Distribution rate | - | - | - |
| Net sales 1 | 0.4667 | - | - |
| EBITDA 1 | -89.96 | -119.9 | -140.3 |
| EBIT 1 | -90.61 | -120 | -141.3 |
| Net income 1 | -83.44 | -107.1 | -135.7 |
| Net Debt 1 | -379 | -286.1 | -507.9 |
| Reference price 2 | 16.42 | 16.42 | 16.42 |
| Nbr of stocks (in thousands) | 45,651 | - | - |
| Announcement Date | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.3x | 899.86x | -4.67x | - | 799M | |
| 21.73x | 7.77x | 15.6x | 1.37% | 74.69B | |
| 30.56x | 8.79x | 27.4x | 0.04% | 58.81B | |
| 33.6x | 6.04x | 18.08x | 0.96% | 48.45B | |
| -20.7x | 214.73x | -22.18x | -.--% | 42.84B | |
| 33.49x | 3.25x | 14.04x | -.--% | 42.79B | |
| 48.17x | 5.48x | 30.1x | -.--% | 41.25B | |
| 27.6x | 7.84x | 20.39x | 0.41% | 31.13B | |
| 35.01x | 7.5x | 19.48x | -.--% | 30.28B | |
| -14.91x | 5.52x | -6.94x | -.--% | 24.05B | |
| Average | 18.83x | 116.68x | 11.13x | 0.31% | 39.51B | |
| Weighted average by Cap. | 23.13x | 31.07x | 14.17x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ATTO Stock
- Valuation Attovia Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
